Arq Bras Endocrinol Metab 2010;54(9):856-857
Hyperprolactinemia: new assay more specific for the monomeric form does not eliminate screening for macroprolactin with polyethylene glycol precipitation
DOI: 10.1590/S0004-27302010000900013
DOI: 10.1590/S0004-27302010000900013
Flow diagram of patient exclusion criteria for SNMTC and FNMTC groups.
Vieira JGH, Tachibana TT, Ferrer CM, Sá J, Biscolla RP, Hoff AO, Kanashiro I. Hyperprolactinemia: new assay more specific for the monomeric form does not eliminate screening for macroprolactin with polyethylene glycol precipitation. Arq Bras Endocrinol Metab 2010;54(9):856-7.
Vieira, José Gilberto H.; Tachibana, Teresinha T.; Ferrer, Cláudia M.; Sá, José de; Biscolla, Rosa Paula; Hoff, Ana O.; Kanashiro, Ina. Hyperprolactinemia: new assay more specific for the monomeric form does not eliminate screening for macroprolactin with polyethylene glycol precipitation. Arq Bras Endocrinol Metab, v. 54, n. 9, p. 856-857, Dec. 2010.
Vieira, J. G. H., Tachibana, T. T., Ferrer, C. M., Sá, J. , Biscolla, R. P., Hoff, A. O., & Kanashiro, I. (2010). Hyperprolactinemia: new assay more specific for the monomeric form does not eliminate screening for macroprolactin with polyethylene glycol precipitation. Arq Bras Endocrinol Metab, 54(9), 856-857.
Vieira, José Gilberto H. and Tachibana, Teresinha T. and Ferrer, Cláudia M. and Sá, José de and Biscolla, Rosa Paula and Hoff, Ana O. and Kanashiro, Ina. Hyperprolactinemia: new assay more specific for the monomeric form does not eliminate screening for macroprolactin with polyethylene glycol precipitation. Arq Bras Endocrinol Metab [online]. 2010, vol. 54, n. 9, [cited 2026-03-08], pp.856-857. Available from: <https://www.aem-sbem.com/article/hyperprolactinemia-new-assay-more-specific-for-the-monomeric-form-does-not-eliminate-screening-for-macroprolactin-with-polyethylene-glycol-precipitation/>. ISSN 2359-3997.